In light of the fact that normal pathways of differentiation and development are frequently usurped during the process of carcinogenesis, we predict that combined therapeutic approaches targeting crosstalk between the Akt and Prlr-Jak-Stat5 pathways may be particularly effective in the case of breast cancer. This evidence concerns the gene PRLR and breast carcinoma.